Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant
Kyungbo Pharmaceutical announced on the 18th that it passed an on-site manufacturing inspection by the U. S.
Search results for "Bio"
Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”
Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has seen prescriptions rise sharply...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?
Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
Hanmi Pharmaceutical, CEO Park Jae-hyun Steps Down: Hwang Sang-yeon Appointed as New CEO Candidate
Hanmi Science is replacing CEO Park Jae-hyun of its subsidiary Hanmi Pharmaceutical and forming a new board of...
Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation
Alteogen announced on the 12th that it has secured registration with the United States Patent and Trademark Office for...
Restoring the Breath of Night: The Potential for a Sleep Apnea Pill
Obstructive sleep apnea , a condition where breathing repeatedly stops during sleep, is far more than a mere snoring...
Why Rokit Healthcare’s Stock Soared Despite Geopolitical Volatility
Rokit Healthcare is capturing significant market attention for its robust momentum. Its stock price has surged 50% over...
Daewoong Pharmaceutical: Early Arrhythmia Detection Through Wearable ‘MobiCare’ Device
A woman in her late 60s who experienced persistent chest pain while walking uphill recently discovered a hidden heart...
SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment
SK Chemicals has announced the release of a new high-dose version of Joins, its flagship natural product-based...
Daewoong Pharmaceutical: Record "Nabota" Sales Clouded by Looming Legal Risks
As Daewoong Pharmaceutical celebrates record-breaking financial results driven by its flagship botulinum toxin, Nabota,...